Abstract Details

Title A potential role for continuation of natalizumab therapy in patients with secondary progressive multiple sclerosis.

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 358

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Siew Mei Yap, MBBS (National Hospital for Neurology and Neurosurgery) PRESENTER	Dr. Yap has received research support from Novartis.
Nuala McNicholas, MBBS (St. Vincent'S University Hospital)	Dr. McNicholas has nothing to disclose.
Niall Tubridy, MD (St Vincent's University Hospital)	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Adrienne Visani	Ms. Visani has nothing to disclose.
	No disclosure on file

��ɫ��